• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ZLD

ZELIRA THERAPEUTICS LIMITED - Announcements

7.32% ! 38.0¢
Market Cap $4.520M  !

Zelira Therapeutics Limited is an Australia-based biopharmaceutical company. The Company... Zelira Therapeutics Limited is an Australia-based biopharmaceutical company. The Company is engaged in the research, development and commercialization of clinically validated cannabinoid-based medicines. It owns a portfolio of products and a pipeline of candidates undergoing clinical development positioned to enter global markets. It is focused on developing and clinically validating branded cannabinoid-based medicines in its prescription (Rx) business for the treatment of a variety of medical conditions, including insomnia, autism and chronic non-cancer pain, as well as offering over the counter (OTC) products. It has two medications: HOPE and ZENIVOL. ZENIVOL is a cannabinoid-based medicine for the treatment of chronic insomnia. The Company in partnership with SprinJeneCBD, introduced a full line of oral care products, including SprinJeneCBD toothpaste product, which is a hemp-derived, oral care products containing cannabinoids, blackseed oil and zinc utilizing patented technology.More

Announcements



Filters [Clear]
  • Price Sensitive: Yes
ZLD Preliminary Final ReportPRICE SENSITIVE29/08/25 download Created with Sketch. 331.11KB
ZLD Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE30/07/25 download Created with Sketch. 1.41MB
ZLD Zelira Therapeutics Secures R&D Loan FacilityPRICE SENSITIVE24/07/25 download Created with Sketch. 1.65MB
ZLD Publication of ZLT-L-007 IRB Approved Observational StudyPRICE SENSITIVE22/05/25 download Created with Sketch. 2.41MB
ZLD Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE29/04/25 download Created with Sketch. 2.11MB
ZLD Zelira secures $1 Million At-the-Market Funding FacilityPRICE SENSITIVE31/03/25 download Created with Sketch. 1.94MB
ZLD Appendix 4D & FY25 Interim Financial ReportPRICE SENSITIVE26/02/25 download Created with Sketch. 3.46MB
ZLD Zelira receives $1,153,000 R&D Tax Incentive Scheme RefundPRICE SENSITIVE18/02/25 download Created with Sketch. 1.36MB
ZLD Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE30/01/25 download Created with Sketch. 1.83MB
ZLD Zeliras HOPE SPV Secures US$681,000 Fourth Funding TranchePRICE SENSITIVE28/01/25 download Created with Sketch. 1.54MB
ZLD Appendix 4C Cash Flow ReportPRICE SENSITIVE29/10/24 download Created with Sketch. 205.83KB
ZLD September 2024 Quarterly Activities ReportPRICE SENSITIVE29/10/24 download Created with Sketch. 1.65MB
ZLD Appendix 4E and Financial Report to ShareholdersPRICE SENSITIVE28/08/24 download Created with Sketch. 10.32MB
ZLD Appendix 4C Cash Flow ReportPRICE SENSITIVE30/07/24 download Created with Sketch. 199.55KB
ZLD June 2024 Quarterly Activities ReportPRICE SENSITIVE30/07/24 download Created with Sketch. 436.18KB
ZLD ZLD Advances HOPE Autism Drug Program with U.S FDA MeetingPRICE SENSITIVE11/07/24 download Created with Sketch. 1.9MB
ZLD ZLD secures US$1.4M unsecured Chairman loan facilityPRICE SENSITIVE01/07/24 download Created with Sketch. 259.96KB
ZLD HOPE SPV receives US$681,000 third tranche of fundingPRICE SENSITIVE23/05/24 download Created with Sketch. 1.36MB
ZLD Appendix 4C Cash Flow ReportPRICE SENSITIVE29/04/24 download Created with Sketch. 201.21KB
ZLD March 2024 Quarterly Activities ReportPRICE SENSITIVE29/04/24 download Created with Sketch. 1.81MB
ZLD Zelira receives $919,000 R&D Tax Incentive Scheme RefundPRICE SENSITIVE15/04/24 download Created with Sketch. 1.49MB
ZLD Appendix 4D & FY24 Interim Financial ReportPRICE SENSITIVE22/02/24 download Created with Sketch. 4.98MB
ZLD Appendix 4C Cash Flow ReportPRICE SENSITIVE31/01/24 download Created with Sketch. 393.48KB
ZLD December 2023 Quarterly Activities ReportPRICE SENSITIVE31/01/24 download Created with Sketch. 1.49MB
ZLD HOPE SPV receives US$819,000 second tranche of fundingPRICE SENSITIVE08/01/24 download Created with Sketch. 1.79MB
ZLD Appendix 4C Cash Flow ReportPRICE SENSITIVE31/10/23 download Created with Sketch. 199KB
ZLD September 2023 Quarterly Activities ReportPRICE SENSITIVE31/10/23 download Created with Sketch. 1.58MB
ZLD Preliminary Final ReportPRICE SENSITIVE31/08/23 download Created with Sketch. 349.94KB
ZLD Zelira closes $3.25M funding as part of HOPE SPV fundraisePRICE SENSITIVE17/08/23 download Created with Sketch. 3.32MB
ZLD Appendix 4C Cash Flow ReportPRICE SENSITIVE31/07/23 download Created with Sketch. 171.01KB
ZLD June 2023 Quarterly Activities ReportPRICE SENSITIVE31/07/23 download Created with Sketch. 1.72MB
ZLD Zeliras diabetic nerve pain drug outperforms LyricaPRICE SENSITIVE31/05/23 download Created with Sketch. 401.78KB
ZLD Trading HaltPRICE SENSITIVE29/05/23 download Created with Sketch. 282.45KB
ZLD ZLD secures additional US$3.25M investment in HOPE SPVPRICE SENSITIVE22/05/23 download Created with Sketch. 577.78KB
ZLD Appendix 4C Cash Flow ReportPRICE SENSITIVE27/04/23 download Created with Sketch. 158.23KB
ZLD March 2023 Quarterly Activities ReportPRICE SENSITIVE27/04/23 download Created with Sketch. 1.61MB
ZLD Zelira raises A$1.77 million from US-based investorsPRICE SENSITIVE15/03/23 download Created with Sketch. 1.11MB
ZLD Trading HaltPRICE SENSITIVE13/03/23 download Created with Sketch. 610.74KB
ZLD Appendix 4D & FY23 Interim Financial ReportPRICE SENSITIVE28/02/23 download Created with Sketch. 3.4MB
ZLD Zelira Executive Director AppointedPRICE SENSITIVE20/02/23 download Created with Sketch. 505.42KB
ZLD Trading HaltPRICE SENSITIVE17/02/23 download Created with Sketch. 281.75KB
ZLD ZLD secures US$8.6 million funding for HOPE 1 US FDA trialsPRICE SENSITIVE15/02/23 download Created with Sketch. 991.52KB
ZLD Trading HaltPRICE SENSITIVE13/02/23 download Created with Sketch. 282.11KB
ZLD Appendix 4C Cash Flow ReportPRICE SENSITIVE31/01/23 download Created with Sketch. 169.11KB
ZLD December 2022 Quarterly Activities ReportPRICE SENSITIVE31/01/23 download Created with Sketch. 1.61MB
ZLD Zelira receives $1.14 million cash R&D Tax IncentivePRICE SENSITIVE30/01/23 download Created with Sketch. 1.09MB
ZLD Partial Receipt and variation of Health House loanPRICE SENSITIVE21/11/22 download Created with Sketch. 1.14MB
ZLD ZLD Completes Enrolment for Diabetic Nerve Pain Drug TrialPRICE SENSITIVE21/11/22 download Created with Sketch. 2.27MB
ZLD Appendix 4C Cash Flow ReportPRICE SENSITIVE31/10/22 download Created with Sketch. 168.43KB
ZLD September 2022 Quarterly Activities ReportPRICE SENSITIVE31/10/22 download Created with Sketch. 1.82MB
ZLD ZLDs Diabetic Nerve Pain Drug Trial Two-Thirds EnrolledPRICE SENSITIVE15/09/22 download Created with Sketch. 1.2MB
ZLD Appendix 4E and Financial Report to ShareholdersPRICE SENSITIVE31/08/22 download Created with Sketch. 1.22MB
ZLD Response to ASX Aware QueryPRICE SENSITIVE05/08/22 download Created with Sketch. 848.36KB
ZLD June 2022 Quarterly Activities ReportPRICE SENSITIVE29/07/22 download Created with Sketch. 1.95MB
ZLD Appendix 4C Cash Flow ReportPRICE SENSITIVE29/07/22 download Created with Sketch. 156.55KB
ZLD Response to ASX Aware QueryPRICE SENSITIVE18/07/22 download Created with Sketch. 842.09KB
ZLD Response to ASX Price QueryPRICE SENSITIVE13/07/22 download Created with Sketch. 285.76KB
ZLD Zenivol receives formal BfArM approval in GermanyPRICE SENSITIVE13/07/22 download Created with Sketch. 1.37MB
ZLD Trading HaltPRICE SENSITIVE12/07/22 download Created with Sketch. 605.07KB
ZLD Pause in TradingPRICE SENSITIVE12/07/22 download Created with Sketch. 114.78KB
ZLD Termination of Scheme Implementation Deed with HHIPRICE SENSITIVE22/06/22 download Created with Sketch. 1.19MB
ZLD Trading HaltPRICE SENSITIVE20/06/22 download Created with Sketch. 603.21KB
ZLD Pause in TradingPRICE SENSITIVE20/06/22 download Created with Sketch. 114.38KB
ZLD EDCDM Technology License Agreement UpdatePRICE SENSITIVE14/06/22 download Created with Sketch. 234.71KB
ZLD Zenivol Longitudinal, RWD Trial in Insomnia ResultsPRICE SENSITIVE08/06/22 download Created with Sketch. 1.84MB
ZLD ZLD Completes Enrolment for Diabetic Nerve Pain Drug TrialPRICE SENSITIVE30/05/22 download Created with Sketch. 2.12MB
ZLD Hope 1 Longitudinal, Real-World Data Trial in ASD ResultsPRICE SENSITIVE17/05/22 download Created with Sketch. 603.74KB
ZLD Appendix 4C Cash Flow ReportPRICE SENSITIVE29/04/22 download Created with Sketch. 155.52KB
ZLD March 2022 Quarterly Activities ReportPRICE SENSITIVE29/04/22 download Created with Sketch. 2.04MB
ZLD HHI: Zelira Therapeutics Ltd to acquire Health HousePRICE SENSITIVE24/02/22 download Created with Sketch. 228.09KB
ZLD Zelira to acquire Health House International LimitedPRICE SENSITIVE24/02/22 download Created with Sketch. 1.71MB
ZLD Appendix 4D & FY22 Interim Financial ReportPRICE SENSITIVE23/02/22 download Created with Sketch. 3.51MB
ZLD Appendix 4C Cash Flow ReportPRICE SENSITIVE31/01/22 download Created with Sketch. 155.51KB
ZLD December 2021 Quarterly Activities ReportPRICE SENSITIVE31/01/22 download Created with Sketch. 2.66MB
ZLD Zelira receives $1.2 million cash R&D Tax IncentivePRICE SENSITIVE12/01/22 download Created with Sketch. 1.22MB
ZLD Partial Receipt Of Zeliras EDCDM Technology License FeePRICE SENSITIVE10/01/22 download Created with Sketch. 1.92MB
ZLD Zelira expands into NZ via exclusive distribution agreementPRICE SENSITIVE16/12/21 download Created with Sketch. 1.77MB
ZLD ZLD Supports Levins Chronic Pain Trial Ethics ApprovalPRICE SENSITIVE02/12/21 download Created with Sketch. 1.72MB
ZLD Zelira Develops Technology and Signs New Licensing DealPRICE SENSITIVE03/11/21 download Created with Sketch. 948.88KB
ZLD September 2021 Quarterly Activities ReportPRICE SENSITIVE29/10/21 download Created with Sketch. 2.29MB
ZLD Appendix 4C Cash Flow ReportPRICE SENSITIVE29/10/21 download Created with Sketch. 156.4KB
ZLD Zelira Raises US$5 Million from US FundPRICE SENSITIVE20/10/21 download Created with Sketch. 2.09MB
ZLD Trading HaltPRICE SENSITIVE19/10/21 download Created with Sketch. 317.01KB
ZLD Zelira Launches RAF FIVE Acne Treatment ProductsPRICE SENSITIVE23/09/21 download Created with Sketch. 3.69MB
ZLD Zelira enters Germany via Exclusive Distribution AgreementPRICE SENSITIVE20/09/21 download Created with Sketch. 1.52MB
ZLD Appendix 4E and Financial Report to ShareholdersPRICE SENSITIVE30/08/21 download Created with Sketch. 1.15MB
ZLD Appendix 4C - quarterlyPRICE SENSITIVE30/07/21 download Created with Sketch. 155.52KB
ZLD June 2021 Quarterly Activities ReportPRICE SENSITIVE30/07/21 download Created with Sketch. 578.95KB
ZLD US Observational Clinical Pain Trial Receives IRB ApprovalPRICE SENSITIVE12/07/21 download Created with Sketch. 217.81KB
ZLD Cantor Fitzgerald - Investor PresentationPRICE SENSITIVE30/06/21 download Created with Sketch. 3.88MB
ZLD Research Demonstrates Significant Uptake of CBD Into BrainPRICE SENSITIVE18/06/21 download Created with Sketch. 260.31KB
ZLD Zelira to Launch CBD Toothpaste in the United KingdomPRICE SENSITIVE15/06/21 download Created with Sketch. 163.18KB
ZLD ZLD and Levin Health to Conduct Chronic Pain Clinical TrialPRICE SENSITIVE03/06/21 download Created with Sketch. 189.07KB
ZLD Zeliras HOPE Range of Products Launches in Washington DCPRICE SENSITIVE06/05/21 download Created with Sketch. 155.24KB
ZLD March 2021 Quarterly ReportPRICE SENSITIVE21/04/21 download Created with Sketch. 191.43KB
ZLD Appendix 4C - quarterlyPRICE SENSITIVE21/04/21 download Created with Sketch. 156.1KB
ZLD Zelira Announces Record Third Quarter RevenuePRICE SENSITIVE15/04/21 download Created with Sketch. 176.22KB
ZLD Appendix 4D & FY21 Interim Financial ReportPRICE SENSITIVE22/02/21 download Created with Sketch. 857.75KB
ZLD Strategic Transition and Executive ChangesPRICE SENSITIVE15/02/21 download Created with Sketch. 154.8KB
ZLD Appendix 4C - quarterlyPRICE SENSITIVE29/01/21 download Created with Sketch. 155.7KB
ZLD Preliminary Final Report
29/08/25PRICE SENSITIVE download Created with Sketch. 331.11KB
ZLD Quarterly Activities/Appendix 4C Cash Flow Report
30/07/25PRICE SENSITIVE download Created with Sketch. 1.41MB
ZLD Zelira Therapeutics Secures R&D Loan Facility
24/07/25PRICE SENSITIVE download Created with Sketch. 1.65MB
ZLD Publication of ZLT-L-007 IRB Approved Observational Study
22/05/25PRICE SENSITIVE download Created with Sketch. 2.41MB
ZLD Quarterly Activities/Appendix 4C Cash Flow Report
29/04/25PRICE SENSITIVE download Created with Sketch. 2.11MB
ZLD Zelira secures $1 Million At-the-Market Funding Facility
31/03/25PRICE SENSITIVE download Created with Sketch. 1.94MB
ZLD Appendix 4D & FY25 Interim Financial Report
26/02/25PRICE SENSITIVE download Created with Sketch. 3.46MB
ZLD Zelira receives $1,153,000 R&D Tax Incentive Scheme Refund
18/02/25PRICE SENSITIVE download Created with Sketch. 1.36MB
ZLD Quarterly Activities/Appendix 4C Cash Flow Report
30/01/25PRICE SENSITIVE download Created with Sketch. 1.83MB
ZLD Zeliras HOPE SPV Secures US$681,000 Fourth Funding Tranche
28/01/25PRICE SENSITIVE download Created with Sketch. 1.54MB
ZLD Appendix 4C Cash Flow Report
29/10/24PRICE SENSITIVE download Created with Sketch. 205.83KB
ZLD September 2024 Quarterly Activities Report
29/10/24PRICE SENSITIVE download Created with Sketch. 1.65MB
ZLD Appendix 4E and Financial Report to Shareholders
28/08/24PRICE SENSITIVE download Created with Sketch. 10.32MB
ZLD Appendix 4C Cash Flow Report
30/07/24PRICE SENSITIVE download Created with Sketch. 199.55KB
ZLD June 2024 Quarterly Activities Report
30/07/24PRICE SENSITIVE download Created with Sketch. 436.18KB
ZLD ZLD Advances HOPE Autism Drug Program with U.S FDA Meeting
11/07/24PRICE SENSITIVE download Created with Sketch. 1.9MB
ZLD ZLD secures US$1.4M unsecured Chairman loan facility
01/07/24PRICE SENSITIVE download Created with Sketch. 259.96KB
ZLD HOPE SPV receives US$681,000 third tranche of funding
23/05/24PRICE SENSITIVE download Created with Sketch. 1.36MB
ZLD Appendix 4C Cash Flow Report
29/04/24PRICE SENSITIVE download Created with Sketch. 201.21KB
ZLD March 2024 Quarterly Activities Report
29/04/24PRICE SENSITIVE download Created with Sketch. 1.81MB
ZLD Zelira receives $919,000 R&D Tax Incentive Scheme Refund
15/04/24PRICE SENSITIVE download Created with Sketch. 1.49MB
ZLD Appendix 4D & FY24 Interim Financial Report
22/02/24PRICE SENSITIVE download Created with Sketch. 4.98MB
ZLD Appendix 4C Cash Flow Report
31/01/24PRICE SENSITIVE download Created with Sketch. 393.48KB
ZLD December 2023 Quarterly Activities Report
31/01/24PRICE SENSITIVE download Created with Sketch. 1.49MB
ZLD HOPE SPV receives US$819,000 second tranche of funding
08/01/24PRICE SENSITIVE download Created with Sketch. 1.79MB
ZLD Appendix 4C Cash Flow Report
31/10/23PRICE SENSITIVE download Created with Sketch. 199KB
ZLD September 2023 Quarterly Activities Report
31/10/23PRICE SENSITIVE download Created with Sketch. 1.58MB
ZLD Preliminary Final Report
31/08/23PRICE SENSITIVE download Created with Sketch. 349.94KB
ZLD Zelira closes $3.25M funding as part of HOPE SPV fundraise
17/08/23PRICE SENSITIVE download Created with Sketch. 3.32MB
ZLD Appendix 4C Cash Flow Report
31/07/23PRICE SENSITIVE download Created with Sketch. 171.01KB
ZLD June 2023 Quarterly Activities Report
31/07/23PRICE SENSITIVE download Created with Sketch. 1.72MB
ZLD Zeliras diabetic nerve pain drug outperforms Lyrica
31/05/23PRICE SENSITIVE download Created with Sketch. 401.78KB
ZLD Trading Halt
29/05/23PRICE SENSITIVE download Created with Sketch. 282.45KB
ZLD ZLD secures additional US$3.25M investment in HOPE SPV
22/05/23PRICE SENSITIVE download Created with Sketch. 577.78KB
ZLD Appendix 4C Cash Flow Report
27/04/23PRICE SENSITIVE download Created with Sketch. 158.23KB
ZLD March 2023 Quarterly Activities Report
27/04/23PRICE SENSITIVE download Created with Sketch. 1.61MB
ZLD Zelira raises A$1.77 million from US-based investors
15/03/23PRICE SENSITIVE download Created with Sketch. 1.11MB
ZLD Trading Halt
13/03/23PRICE SENSITIVE download Created with Sketch. 610.74KB
ZLD Appendix 4D & FY23 Interim Financial Report
28/02/23PRICE SENSITIVE download Created with Sketch. 3.4MB
ZLD Zelira Executive Director Appointed
20/02/23PRICE SENSITIVE download Created with Sketch. 505.42KB
ZLD Trading Halt
17/02/23PRICE SENSITIVE download Created with Sketch. 281.75KB
ZLD ZLD secures US$8.6 million funding for HOPE 1 US FDA trials
15/02/23PRICE SENSITIVE download Created with Sketch. 991.52KB
ZLD Trading Halt
13/02/23PRICE SENSITIVE download Created with Sketch. 282.11KB
ZLD Appendix 4C Cash Flow Report
31/01/23PRICE SENSITIVE download Created with Sketch. 169.11KB
ZLD December 2022 Quarterly Activities Report
31/01/23PRICE SENSITIVE download Created with Sketch. 1.61MB
ZLD Zelira receives $1.14 million cash R&D Tax Incentive
30/01/23PRICE SENSITIVE download Created with Sketch. 1.09MB
ZLD Partial Receipt and variation of Health House loan
21/11/22PRICE SENSITIVE download Created with Sketch. 1.14MB
ZLD ZLD Completes Enrolment for Diabetic Nerve Pain Drug Trial
21/11/22PRICE SENSITIVE download Created with Sketch. 2.27MB
ZLD Appendix 4C Cash Flow Report
31/10/22PRICE SENSITIVE download Created with Sketch. 168.43KB
ZLD September 2022 Quarterly Activities Report
31/10/22PRICE SENSITIVE download Created with Sketch. 1.82MB
ZLD ZLDs Diabetic Nerve Pain Drug Trial Two-Thirds Enrolled
15/09/22PRICE SENSITIVE download Created with Sketch. 1.2MB
ZLD Appendix 4E and Financial Report to Shareholders
31/08/22PRICE SENSITIVE download Created with Sketch. 1.22MB
ZLD Response to ASX Aware Query
05/08/22PRICE SENSITIVE download Created with Sketch. 848.36KB
ZLD June 2022 Quarterly Activities Report
29/07/22PRICE SENSITIVE download Created with Sketch. 1.95MB
ZLD Appendix 4C Cash Flow Report
29/07/22PRICE SENSITIVE download Created with Sketch. 156.55KB
ZLD Response to ASX Aware Query
18/07/22PRICE SENSITIVE download Created with Sketch. 842.09KB
ZLD Response to ASX Price Query
13/07/22PRICE SENSITIVE download Created with Sketch. 285.76KB
ZLD Zenivol receives formal BfArM approval in Germany
13/07/22PRICE SENSITIVE download Created with Sketch. 1.37MB
ZLD Trading Halt
12/07/22PRICE SENSITIVE download Created with Sketch. 605.07KB
ZLD Pause in Trading
12/07/22PRICE SENSITIVE download Created with Sketch. 114.78KB
ZLD Termination of Scheme Implementation Deed with HHI
22/06/22PRICE SENSITIVE download Created with Sketch. 1.19MB
ZLD Trading Halt
20/06/22PRICE SENSITIVE download Created with Sketch. 603.21KB
ZLD Pause in Trading
20/06/22PRICE SENSITIVE download Created with Sketch. 114.38KB
ZLD EDCDM Technology License Agreement Update
14/06/22PRICE SENSITIVE download Created with Sketch. 234.71KB
ZLD Zenivol Longitudinal, RWD Trial in Insomnia Results
08/06/22PRICE SENSITIVE download Created with Sketch. 1.84MB
ZLD ZLD Completes Enrolment for Diabetic Nerve Pain Drug Trial
30/05/22PRICE SENSITIVE download Created with Sketch. 2.12MB
ZLD Hope 1 Longitudinal, Real-World Data Trial in ASD Results
17/05/22PRICE SENSITIVE download Created with Sketch. 603.74KB
ZLD Appendix 4C Cash Flow Report
29/04/22PRICE SENSITIVE download Created with Sketch. 155.52KB
ZLD March 2022 Quarterly Activities Report
29/04/22PRICE SENSITIVE download Created with Sketch. 2.04MB
ZLD HHI: Zelira Therapeutics Ltd to acquire Health House
24/02/22PRICE SENSITIVE download Created with Sketch. 228.09KB
ZLD Zelira to acquire Health House International Limited
24/02/22PRICE SENSITIVE download Created with Sketch. 1.71MB
ZLD Appendix 4D & FY22 Interim Financial Report
23/02/22PRICE SENSITIVE download Created with Sketch. 3.51MB
ZLD Appendix 4C Cash Flow Report
31/01/22PRICE SENSITIVE download Created with Sketch. 155.51KB
ZLD December 2021 Quarterly Activities Report
31/01/22PRICE SENSITIVE download Created with Sketch. 2.66MB
ZLD Zelira receives $1.2 million cash R&D Tax Incentive
12/01/22PRICE SENSITIVE download Created with Sketch. 1.22MB
ZLD Partial Receipt Of Zeliras EDCDM Technology License Fee
10/01/22PRICE SENSITIVE download Created with Sketch. 1.92MB
ZLD Zelira expands into NZ via exclusive distribution agreement
16/12/21PRICE SENSITIVE download Created with Sketch. 1.77MB
ZLD ZLD Supports Levins Chronic Pain Trial Ethics Approval
02/12/21PRICE SENSITIVE download Created with Sketch. 1.72MB
ZLD Zelira Develops Technology and Signs New Licensing Deal
03/11/21PRICE SENSITIVE download Created with Sketch. 948.88KB
ZLD September 2021 Quarterly Activities Report
29/10/21PRICE SENSITIVE download Created with Sketch. 2.29MB
ZLD Appendix 4C Cash Flow Report
29/10/21PRICE SENSITIVE download Created with Sketch. 156.4KB
ZLD Zelira Raises US$5 Million from US Fund
20/10/21PRICE SENSITIVE download Created with Sketch. 2.09MB
ZLD Trading Halt
19/10/21PRICE SENSITIVE download Created with Sketch. 317.01KB
ZLD Zelira Launches RAF FIVE Acne Treatment Products
23/09/21PRICE SENSITIVE download Created with Sketch. 3.69MB
ZLD Zelira enters Germany via Exclusive Distribution Agreement
20/09/21PRICE SENSITIVE download Created with Sketch. 1.52MB
ZLD Appendix 4E and Financial Report to Shareholders
30/08/21PRICE SENSITIVE download Created with Sketch. 1.15MB
ZLD Appendix 4C - quarterly
30/07/21PRICE SENSITIVE download Created with Sketch. 155.52KB
ZLD June 2021 Quarterly Activities Report
30/07/21PRICE SENSITIVE download Created with Sketch. 578.95KB
ZLD US Observational Clinical Pain Trial Receives IRB Approval
12/07/21PRICE SENSITIVE download Created with Sketch. 217.81KB
ZLD Cantor Fitzgerald - Investor Presentation
30/06/21PRICE SENSITIVE download Created with Sketch. 3.88MB
ZLD Research Demonstrates Significant Uptake of CBD Into Brain
18/06/21PRICE SENSITIVE download Created with Sketch. 260.31KB
ZLD Zelira to Launch CBD Toothpaste in the United Kingdom
15/06/21PRICE SENSITIVE download Created with Sketch. 163.18KB
ZLD ZLD and Levin Health to Conduct Chronic Pain Clinical Trial
03/06/21PRICE SENSITIVE download Created with Sketch. 189.07KB
ZLD Zeliras HOPE Range of Products Launches in Washington DC
06/05/21PRICE SENSITIVE download Created with Sketch. 155.24KB
ZLD March 2021 Quarterly Report
21/04/21PRICE SENSITIVE download Created with Sketch. 191.43KB
ZLD Appendix 4C - quarterly
21/04/21PRICE SENSITIVE download Created with Sketch. 156.1KB
ZLD Zelira Announces Record Third Quarter Revenue
15/04/21PRICE SENSITIVE download Created with Sketch. 176.22KB
ZLD Appendix 4D & FY21 Interim Financial Report
22/02/21PRICE SENSITIVE download Created with Sketch. 857.75KB
ZLD Strategic Transition and Executive Changes
15/02/21PRICE SENSITIVE download Created with Sketch. 154.8KB
ZLD Appendix 4C - quarterly
29/01/21PRICE SENSITIVE download Created with Sketch. 155.7KB
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
38.0¢
Change
-0.030(7.32%)
Mkt cap ! $4.520M
Open High Low Value Volume
40.0¢ 42.0¢ 38.0¢ $1.766K 4.48K

Buyers (Bids)

No. Vol. Price($)
3 34234 38.0¢
 

Sellers (Offers)

Price($) Vol. No.
42.0¢ 5666 1
View Market Depth
Last trade - 15.50pm 15/09/2025 (20 minute delay) ?
Last
38.0¢
  Change
-0.030 ( 1.30 %)
Open High Low Volume
38.0¢ 38.0¢ 38.0¢ 1184
Last updated 14.55pm 15/09/2025 ?
ZLD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.